North China Pharmaceutical Group Corp. (NCPC), (simplified Chinese: 华北制药集团有限责任公司; traditional Chinese: 華北制藥集團有限責任公司; pinyin: Huáběi zhìyào jítuán yǒuxiàn zérèn gōngsī) is a pharmaceutical manufacturer in China.

NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China.

NCPC is one of the four groups of the candidate enterprises approved by the China Securities Regulatory Commission for overseas listing.

Nearly 300 experts and technicians, advanced instruments and an integrated pilot unit transform laboratory reactions into large-scale production.

Its original research focuses on natural and small molecular drugs screening, combinatorial chemical technology and modern biotechnologies.